Studies in mice with severe immunodeficiencies and in genetically engineered cell lines suggest that the un-silencing of ERVs triggers an immune response primarily via RNA-sensing associated with the mitochondrial antiviral signaling protein (MAVS) and the Stimulator of Interferon Genes (STING) signaling pathways8,32. This evidence concerns the gene MAVS and immunodeficiency disease.